tetrahydroquinolin
oxocarbaz
pubchem
cid
test
inhibitor
human
cathepsin
l
ec
entri
blocker
sever
acut
respiratori
syndrom
sar
coronaviru
ebola
pseudotyp
viru
cathepsin
l
inhibit
assay
oxocarbaz
caus
timedepend
drop
ic
nm
preincub
nm
preincub
slowli
revers
inhibit
demonstr
dilut
assay
transient
kinet
analysi
use
singlestep
competit
inhibit
model
provid
rate
constant
k
k
k
nm
compound
also
display
cathepsin
lb
select
nontox
human
aortic
endotheli
cell
oxocarbaz
relat
thiocarbaz
pubchem
cid
test
sar
coronaviru
cov
ebola
viruspseudotyp
infect
assay
oxocarbaz
thiocarbaz
demonstr
activ
block
sarscov
ic
nm
ebola
viru
ic
nm
entri
human
embryon
kidney
cell
trace
intracellular
action
inhibitor
intracellular
cathepsin
l
activitybas
probe
alkyl
linkertyrleuepoxid
use
label
activ
site
cystein
proteas
lysat
reduct
activ
cathepsin
l
inhibitortr
cell
correl
well
observ
potenc
inhibitor
observ
viru
pseudotyp
infect
assay
overal
oxocarbaz
cid
subnanomolar
slowbind
revers
inhibitor
human
cathepsin
l
block
sarscov
ebola
pseudotyp
viru
entri
human
cell
cathepsin
l
one
member
human
lysosom
cystein
proteas
ie
b
c
f
h
k
l
v
w
x
fall
famili
papain
famili
ca
clan
rossi
et
al
enzym
tradit
link
nonspecif
proteolyt
activ
within
lysosom
recent
cathepsin
l
implic
regulatori
event
relat
cancer
diabet
immunolog
respons
degrad
articular
cartilag
matrix
patholog
process
chapman
et
al
turk
guncar
maehr
et
al
vasiljeva
et
al
includ
osteoporosi
rheumatoid
arthriti
tumor
metastasi
mcgrath
turk
et
al
pott
et
al
schedel
et
al
palermo
joyc
inhibitor
cathepsin
l
block
viral
entri
sever
acut
respiratori
syndrom
coronaviru
sarscov
ebola
viru
impair
convers
hendra
viru
glycoprotein
matur
activ
form
chandran
et
al
pager
dutch
simmon
et
al
respect
develop
antivir
agent
inhibitor
human
cathepsin
l
subject
resist
rapid
mutat
viral
genom
cathepsin
l
therefor
attract
target
drug
develop
sarscov
infect
result
case
infect
death
enserink
viru
uptak
follow
angiotensinconvert
enzym
receptor
bind
cathepsin
lmediat
proteolysi
induc
conform
chang
sarscov
glycoprotein
trigger
endosom
membran
fusion
process
simmon
et
al
likewis
cleavag
ebola
glycoprotein
cathepsin
l
reveal
receptor
interact
domain
within
gp
cathepsin
l
activ
requir
entri
host
cell
chandran
et
al
schornberg
et
al
lee
et
al
ebola
viru
caus
fatal
hemorrhag
fever
first
outbreak
report
sudan
zair
feldmann
et
al
inhibit
cathepsin
l
thu
hold
promis
therapeut
intervent
sarscov
ebola
viru
infect
high
throughput
screen
cathepsin
l
inhibitor
first
identifi
methylsulfanylcarbonyl
hydrazino
carbam
acid
tertbutyl
ester
pubm
cid
fig
novel
thiocarbaz
compound
exhibit
potent
inhibit
cathepsin
l
myer
et
al
shah
et
al
molecular
dock
simul
thiocarbaz
papain
structur
reveal
key
contact
ligandprotein
interact
addit
medicin
chemistri
effort
result
synthesi
even
potent
tetrahydroquinolin
oxocarbaz
compound
propionyl
hydrazinecarboxyl
acid
ester
pubm
cid
fig
myer
et
al
b
articl
full
kinet
character
oxocarbaz
inhibitor
report
along
measur
potenc
block
entri
sarscov
ebola
viru
pseudotyp
compound
display
ic
nm
prevent
cell
infect
ebola
sarscov
pseudotyp
respect
label
intracellular
activ
cathepsin
l
use
activ
base
probe
permit
quantit
estim
interact
cathepsin
l
inhibitor
target
enzym
hek
cell
cathepsin
l
assay
describ
prior
work
cathepsin
l
assay
carri
use
zpheargamc
sigma
st
loui
mo
ngml
human
liver
cathepsin
l
calbiochem
san
diego
ca
assay
buffer
consist
mm
sodium
acet
mm
edta
mm
cystein
ph
enzym
incub
buffer
min
ensur
catalyt
cystein
reduc
form
enzymat
reaction
read
envis
floresc
micropl
reader
perkinelm
life
analyt
scienc
waltham
fluoresc
signal
measur
excit
emiss
wavelength
nm
respect
cid
store
mm
dimethyl
sulfoxid
dmso
aliquot
use
fresh
experi
sampl
cid
obtain
nation
institut
health
molecular
librari
small
molecul
repositori
biofocu
south
san
francisco
ca
inhibitor
potenc
determin
serial
dilut
doserespons
assay
perform
triplic
well
assay
plate
corn
life
scienc
acton
contain
l
water
l
inhibitor
dmso
posit
neg
control
present
serv
intern
control
l
dmso
transfer
place
inhibitor
ten
microlit
zpheargamc
concentr
assay
buffer
l
ngml
cathepsin
l
assay
buffer
ad
sequenti
initi
proteas
reaction
total
l
assay
buffer
dispens
place
enzym
neg
control
well
result
final
dose
respons
concentr
rang
nm
inhibitor
dmso
final
reaction
volum
fourparamet
logist
model
idb
xlfit
eq
guildford
surrey
uk
use
fit
measur
data
find
ic
valu
timedepend
inhibit
revers
test
preincub
assay
perform
establish
time
depend
inhibit
enzym
inhibitor
preincub
variou
time
micropl
addit
substrat
initi
enzymat
reaction
total
l
cathepsin
l
ngml
l
cid
variou
concentr
assay
buffer
incub
h
volum
l
zpheargamc
substrat
ad
plate
monitor
amc
hydrolysi
dilut
assay
protocol
deploy
describ
previous
monitor
revers
concentr
mixtur
enzym
ngml
inhibitor
cid
nm
incub
h
dilut
corn
plate
assay
buffer
contain
zpheargamc
final
volum
l
time
calcul
use
system
ordinari
differenti
equat
reaction
step
adopt
paramet
fit
prior
work
progress
curv
inhibitor
concentr
fit
fiveparamet
k
k
k
k
k
cat
kinet
inhibit
model
use
matlab
mathwork
inc
natick
object
function
use
minim
search
comput
sum
squar
rel
error
simul
valu
experiment
data
select
cathepsin
b
cid
assay
inhibit
cathepsin
b
human
liver
cathepsin
b
ngml
calbiochem
san
diego
ca
use
correspond
substrat
zargargamc
reaction
perform
mm
sodium
acet
buffer
contain
mm
cystein
mm
edta
ph
cytotox
cid
test
cytotox
human
aortic
endotheli
cell
describ
previous
cell
seed
cell
l
per
well
plate
plate
centrifug
incub
h
cid
doxorubicin
posit
control
serial
dilut
endotheli
cell
media
lonza
walkersvil
inc
walkersvil
md
total
l
serial
dilut
ad
well
triplic
result
final
concentr
compound
nm
dmso
plate
centrifug
incub
h
total
l
celltiterglo
promega
madison
wi
ad
well
centrifug
min
luminesc
measur
use
envis
micropl
reader
viru
pseudotyp
prepar
viru
infect
assay
pseudovirion
prepar
essenti
describ
previous
kaletski
et
al
brief
cell
cultur
co
dulbecco
modifi
eagl
medium
invitrogen
supplement
fetal
bovin
serum
pseudotyp
produc
transfect
cell
g
hivluciferas
vector
pnlluc
g
plasmid
encod
ebola
glycoprotein
sar
spike
protein
simmon
et
al
kaletski
et
al
vesicular
stomat
viru
glycoprotein
vsvg
pseudovirion
prepar
use
g
vsvgencod
plasmid
virion
concentr
ultracentrifug
rpm
rotor
beckman
coulter
fullerton
ca
sucros
cushion
h
pellet
resuspend
overnight
phosphatebuff
salin
measur
infect
cell
pretreat
h
inhibitor
zvalphecho
sigma
st
loui
mo
posit
control
simmon
et
al
media
remov
replac
inhibitor
doubl
final
concentr
equal
volum
pseudotyp
ad
cell
spininfect
h
spin
infect
cell
incub
h
medium
replac
fresh
medium
without
drug
cell
lysat
assay
luciferas
activ
promega
h
infect
label
activ
cathepsin
l
hek
use
oxocarbaz
cid
thiocarbaz
cid
calbiochem
cathepsin
l
inhibitor
iii
zphetyr
tbu
diazomethylketon
calbiochem
dissolv
dmso
give
mm
stock
solut
alkyl
linkertyrleuepoxid
prepar
describ
previous
greenbaum
et
al
hek
cell
seed
sixwel
tissu
cultur
plate
bd
bioscienc
discoveri
labwar
bedford
concentr
cellswel
inhibitor
ad
well
dilut
give
final
concentr
incub
cell
h
adher
cell
scrap
pellet
lyse
mm
sodium
acet
vv
triton
ph
subject
three
freezethaw
cycl
follow
sonic
branson
ultrason
corpor
danburi
ct
centrifug
rpm
min
supernat
incub
cystein
proteas
probe
greenbaum
et
al
overnight
incub
sampl
g
total
protein
per
lane
mix
nupag
lithium
dodecyl
sulfat
sampl
buffer
invitrogen
carlsbad
ca
sampl
reduc
agent
invitrogen
denatur
min
sdspolyacrylamid
gel
separ
perform
xcell
surelock
system
invitrogen
bistri
gel
invitrogen
v
h
transfer
polyvinyliden
difluorid
membran
v
h
membran
block
casein
solut
vector
laboratori
h
incub
avidin
biotinyl
horseradish
peroxidas
follow
wash
detect
supersign
west
pico
chemiluminesc
substrat
thermo
fisher
scientif
waltham
imag
reader
fujifilm
tokyo
japan
band
intens
quantifi
use
softwar
multi
gaug
fujifilm
confirm
posit
catl
band
membran
later
incub
western
blot
strip
buffer
thermo
fisher
scientif
min
redetect
anticatl
rabbit
polyclon
antibodi
calbiochem
dilut
h
goat
antirabbit
igg
peroxidas
conjug
calbiochem
use
secondari
antibodi
dilut
protein
load
check
use
mous
monoclon
antibodi
sigma
dilut
follow
dilut
goat
antimous
igg
peroxidas
conjug
thermo
fisher
scientif
kinet
human
cathepsin
l
inhibit
cid
found
inhibit
cathepsin
l
ic
nm
assay
immedi
mix
enzym
upon
preincub
cathepsin
l
period
h
tetrahydroquinolin
oxocarbaz
demonstr
timedepend
reduct
ic
nm
h
nm
h
nm
h
fig
demonstr
slow
onrat
inhibit
inhibitor
revers
evalu
use
preincubationdilut
assay
copeland
preincub
enzym
inhibitor
ic
enzym
associ
inhibitor
shown
fig
upon
dilut
buffer
reaction
initi
substrat
total
enzymat
activ
return
preincub
reaction
case
preincub
substrat
cleavag
rate
time
greater
initi
hydrolysi
rate
fig
indic
enzymeinhibitor
complex
slowli
revers
transient
kinet
data
analysi
perform
inhibit
data
oxocarbaz
cid
given
close
structur
resembl
thiocarbaz
cid
inhibit
model
fig
b
use
inhibitor
report
previous
matlab
code
develop
optim
fit
paramet
inhibitor
present
tabl
comparison
slow
onrat
inhibit
clearli
appar
fig
product
format
rate
slowli
drop
assay
best
fit
paramet
cid
k
k
k
cat
k
k
five
paramet
k
k
k
cat
k
vari
substanti
thiocarbaz
cid
oxocarbaz
cid
test
two
slow
onrat
inhibitor
fit
kinet
paramet
k
cid
rate
control
display
rate
almost
five
time
greater
cid
result
calcul
inhibit
constant
oxocarbaz
k
nm
calcul
k
valu
correspond
well
ic
valu
nm
display
preincub
cathespin
l
cid
cathespsin
lb
select
cytotox
ic
cid
human
liver
cathepsin
b
measur
data
shown
preincub
result
cathepsin
lb
select
ratio
consider
higher
select
previous
report
thiocarbaz
cid
prior
work
tert
butyl
n
sulfanylcarbonylhydrazinyl
carbam
pubchem
sid
indic
select
function
time
noteworthi
cid
prove
nontox
human
aortic
endotheli
cell
data
shown
thu
oxocarbaz
inhibitor
tertbutyl
n
carbonylhydrazinyl
carbam
sid
one
potent
select
inhibitor
human
cathepsin
l
report
date
inhibit
viru
pseudotyp
infect
cid
inhibit
entri
sarscov
ic
nm
ebola
viru
ic
nm
pseudotyp
cellular
assay
vsvg
reli
upon
cathepsin
l
activ
singlestep
mechan
simpl
revers
slow
bind
inhibit
b
ordinari
differenti
equat
govern
singlestep
mechan
inhibit
c
nonlinear
regress
transient
dynam
cid
use
code
written
matlab
fit
fiveparamet
inhibit
kinet
model
reaction
progress
curv
f
shown
ngml
human
cathepsin
l
enzym
zpheargamc
substrat
vari
concentr
cid
inhibitor
infect
host
cell
use
control
inhibit
cid
fig
although
cid
reveal
potenc
block
sarscov
ebola
viru
pseudotyp
entri
cell
cid
found
littl
inhibit
either
sarscov
entri
ic
ebola
viral
entri
ic
data
shown
differ
postul
result
differ
cell
permeabl
properti
compound
thu
motiv
assay
intracellular
cathepsin
l
inhibit
exploit
label
probe
inhibit
intracellular
cathepsin
l
cell
incub
four
differ
cathepsin
l
inhibitor
h
permit
time
compound
permeat
cell
membran
interact
cathepsin
l
via
inhibit
activ
site
enzym
chemic
probe
epoxid
electrophil
biotin
tag
greenbaum
et
al
label
activ
cathepsin
l
catalyt
site
intracellular
cathepsin
l
inhibit
incub
would
thu
unabl
bind
probe
especi
given
slow
revers
carbaz
inhibitor
western
blot
fig
band
intens
quantifi
multi
gaug
fujifilm
correl
activ
cathepsin
l
activ
remain
cell
cathepsin
l
band
posit
verifi
fig
protein
load
lane
check
use
fig
quantifi
result
normal
lane
cell
treat
dmso
present
fig
oxocarbaz
inhibitor
cid
caus
reduct
activ
intracellular
cathepsin
l
level
compar
lane
commerci
avail
cystein
proteas
inhibitor
reveal
ic
cathepsin
l
nm
ic
sar
rang
nm
simmon
et
al
posit
control
employ
lane
led
reduct
cathepsin
l
activ
compar
lane
thiocarbaz
inhibitor
cid
howev
affect
cathepsin
l
level
cell
illustr
lane
potenti
indic
poor
cellular
uptak
inhibitor
turn
correl
poor
activ
viral
entri
assay
posit
control
cathepsin
l
inhibitor
iii
calbiochem
diazomethyl
keton
lane
led
reduct
cathepsin
l
activ
compar
lane
oxocarbaz
cid
design
base
knowledg
previous
report
thiocarbaz
chemotyp
myer
et
al
demonstr
subnanomolar
k
nm
slowon
slowoff
inhibitor
human
cathepsin
l
block
sarscov
ebola
pseudotyp
viru
entri
human
cell
ic
valu
nm
respect
minim
vitro
toxic
given
cathepsin
lb
select
oxocarbaz
inhibitor
suggest
inhibit
cathepsin
l
alon
suffici
block
ebola
pseudotyp
viru
entri
hek
cell
without
need
simultan
block
cathepsin
b
individu
kinet
paramet
estim
transient
kinet
analys
reaction
progress
curv
variou
inhibitor
concentr
compar
cid
cid
substanti
higher
k
valu
result
lower
k
improv
rate
bind
cid
cathepsin
l
may
attribut
optim
tetrahydroquinolin
structur
stronger
hydrophob
interact
subsit
better
hydrogen
bond
network
receptor
enzym
observ
predict
dock
pose
ligandenzym
complex
noteworthi
oxocarbaz
thiocarbaz
inhibitor
like
coval
revers
inhibitor
replac
thiocarbaz
sulfur
cid
result
loss
activ
myer
et
al
quit
possibl
mechan
inhibit
involv
tetrahydr
intermedi
attack
activ
site
residu
thiocarbaz
carbonyl
oxocarbaz
carbonyl
difficult
predict
temperatur
depend
ic
directli
measur
found
small
shift
ic
nm
n
ic
nm
n
data
shown
endosom
cathepsin
play
import
role
mediat
viru
entri
host
cell
sarscov
huang
et
al
ebola
viru
schornberg
et
al
particular
cathepsin
l
singl
possibl
play
crucial
role
trigger
membran
fusion
within
endosom
via
proteolysi
simmon
et
al
kaletski
et
al
present
studi
cathepsin
l
inhibitor
cid
demonstr
effect
block
viru
entri
sar
ebola
pseudotyp
infect
result
valid
possibl
prevent
invas
spread
diseas
use
cathepsin
l
inhibitor
establish
oxacarbaz
viabl
candid
optim
design
cid
entail
substitut
tetrahydroquinolin
anilid
moieti
anilid
group
cid
structur
modif
improv
ligandprotein
interact
pocket
demonstr
molecular
dock
studi
addit
hypothes
entrop
consider
contribut
increas
potenc
use
absorpt
distribut
metabol
excret
adm
properti
predict
softwar
qikprop
schroding
llc
new
york
ny
found
cid
predict
log
valu
partit
coeffici
clogp
octanolwat
clogp
higher
cid
estim
clogp
base
condit
inhibitor
uncharg
condit
like
upheld
pk
hur
guven
indol
group
oxocarbaz
thiocarbaz
inhibitor
predict
increas
hydrophob
may
result
higher
permeabl
cid
cell
henc
result
better
potenc
viru
infect
assay
fig
intracellular
inhibit
cathepsin
l
fig
poor
activ
thiocarbaz
cellbas
viral
entri
assay
may
partial
explain
label
assay
thiocarbaz
treatment
littl
effect
block
intracellular
cathepsin
l
activ
tbenzyloxycarbonyl
group
inhibitor
common
amino
protect
group
found
group
prevent
selfcleavag
thiocarbaz
myer
et
al
note
protect
group
may
unstabl
acid
condit
gastrointestin
tract
oral
avail
compound
without
tbenzyloxycarbonyl
protect
group
unknown
taken
togeth
result
studi
demonstr
efficaci
cid
block
viru
entri
human
cell
conjunct
structur
cid
offer
new
start
point
intervent
sar
ebola
viru
infect
novel
probe
explor
mechan
viru
entri
